• Home
  • Medical Devices
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market - Global Outlook and Forecast 2021-2027

Benign Prostatic Hyperplasia (BPH) Treatment Devices Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687385 | No. of Pages: 100 | Category: Medical Devices
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Benign Prostatic Hyperplasia (BPH) Treatment Devices in global, including the following market information:
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Benign Prostatic Hyperplasia (BPH) Treatment Devices companies in 2020 (%)
The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Benign Prostatic Hyperplasia (BPH) Treatment Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Type, 2020 (%)
Surgical Treatment
Minimally Invasive Treatment
Laser Treatment
Other

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Application, 2020 (%)
Fertility Clinics
Hospitals
Others

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices revenues share in global market, 2020 (%)
Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advin Urology
Biolitec
Boston Scientific Corporation
CONMED
Convergent Laser Technologies
CoreTherm Medical, Inc. (ProstaLund)
HistoSonics, Inc.
JenaSurgical GmbH
KARL STORZ
LISA Laser Products GmbH
Lumenis Ltd.
Medifocus, Inc.
Endo International
Medtronic
Siemens
Olympus
Urologix
NeoTract
Urotech
Baxter International
1 Introduction to Research & Analysis Reports
    1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Overall Market Size
    2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size: 2021 VS 2027
    2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Players in Global Market
    3.2 Top Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies Ranked by Revenue
    3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Companies
    3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Companies
    3.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Players in Global Market
        3.8.1 List of Global Tier 1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies
        3.8.2 List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Markets, 2021 & 2027
        4.1.2 Surgical Treatment
        4.1.3 Minimally Invasive Treatment
        4.1.4 Laser Treatment
        4.1.5 Other
    4.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue & Forecasts
        4.2.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2021
        4.2.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2022-2027
        4.2.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
    4.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales & Forecasts
        4.3.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2021
        4.3.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2022-2027
        4.3.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
    4.4 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2021 & 2027
        5.1.2 Fertility Clinics
        5.1.3 Hospitals
        5.1.4 Others
    5.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue & Forecasts
        5.2.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2021
        5.2.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2022-2027
        5.2.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
    5.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales & Forecasts
        5.3.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2021
        5.3.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2022-2027
        5.3.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
    5.4 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2021 & 2027
    6.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue & Forecasts
        6.2.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2021
        6.2.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2022-2027
        6.2.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
    6.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales & Forecasts
        6.3.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2021
        6.3.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2022-2027
        6.3.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
        6.4.2 By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
        6.4.3 US Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.4.4 Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.4.5 Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
        6.5.2 By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
        6.5.3 Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.5.4 France Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.5.5 U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.5.6 Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.5.7 Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.5.8 Nordic Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.5.9 Benelux Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
        6.6.2 By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
        6.6.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.6.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.6.5 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.6.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.6.7 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
        6.7.2 By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
        6.7.3 Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.7.4 Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
        6.8.3 Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.8.4 Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.8.5 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
        6.8.6 UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Advin Urology
        7.1.1 Advin Urology Corporate Summary
        7.1.2 Advin Urology Business Overview
        7.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.1.4 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.1.5 Advin Urology Key News
    7.2 Biolitec
        7.2.1 Biolitec Corporate Summary
        7.2.2 Biolitec Business Overview
        7.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.2.4 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.2.5 Biolitec Key News
    7.3 Boston Scientific Corporation
        7.3.1 Boston Scientific Corporation Corporate Summary
        7.3.2 Boston Scientific Corporation Business Overview
        7.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.3.5 Boston Scientific Corporation Key News
    7.4 CONMED
        7.4.1 CONMED Corporate Summary
        7.4.2 CONMED Business Overview
        7.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.4.4 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.4.5 CONMED Key News
    7.5 Convergent Laser Technologies
        7.5.1 Convergent Laser Technologies Corporate Summary
        7.5.2 Convergent Laser Technologies Business Overview
        7.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.5.4 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.5.5 Convergent Laser Technologies Key News
    7.6 CoreTherm Medical, Inc. (ProstaLund)
        7.6.1 CoreTherm Medical, Inc. (ProstaLund) Corporate Summary
        7.6.2 CoreTherm Medical, Inc. (ProstaLund) Business Overview
        7.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.6.4 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.6.5 CoreTherm Medical, Inc. (ProstaLund) Key News
    7.7 HistoSonics, Inc.
        7.7.1 HistoSonics, Inc. Corporate Summary
        7.7.2 HistoSonics, Inc. Business Overview
        7.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.4.4 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.7.5 HistoSonics, Inc. Key News
    7.8 JenaSurgical GmbH
        7.8.1 JenaSurgical GmbH Corporate Summary
        7.8.2 JenaSurgical GmbH Business Overview
        7.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.8.4 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.8.5 JenaSurgical GmbH Key News
    7.9 KARL STORZ
        7.9.1 KARL STORZ Corporate Summary
        7.9.2 KARL STORZ Business Overview
        7.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.9.4 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.9.5 KARL STORZ Key News
    7.10 LISA Laser Products GmbH
        7.10.1 LISA Laser Products GmbH Corporate Summary
        7.10.2 LISA Laser Products GmbH Business Overview
        7.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.10.4 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.10.5 LISA Laser Products GmbH Key News
    7.11 Lumenis Ltd.
        7.11.1 Lumenis Ltd. Corporate Summary
        7.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Business Overview
        7.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.11.4 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.11.5 Lumenis Ltd. Key News
    7.12 Medifocus, Inc.
        7.12.1 Medifocus, Inc. Corporate Summary
        7.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Business Overview
        7.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.12.4 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.12.5 Medifocus, Inc. Key News
    7.13 Endo International
        7.13.1 Endo International Corporate Summary
        7.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Business Overview
        7.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.13.4 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.13.5 Endo International Key News
    7.14 Medtronic
        7.14.1 Medtronic Corporate Summary
        7.14.2 Medtronic Business Overview
        7.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.14.4 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.14.5 Medtronic Key News
    7.15 Siemens
        7.15.1 Siemens Corporate Summary
        7.15.2 Siemens Business Overview
        7.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.15.4 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.15.5 Siemens Key News
    7.16 Olympus
        7.16.1 Olympus Corporate Summary
        7.16.2 Olympus Business Overview
        7.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.16.4 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.16.5 Olympus Key News
    7.17 Urologix
        7.17.1 Urologix Corporate Summary
        7.17.2 Urologix Business Overview
        7.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.17.4 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.17.5 Urologix Key News
    7.18 NeoTract
        7.18.1 NeoTract Corporate Summary
        7.18.2 NeoTract Business Overview
        7.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.18.4 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.18.5 NeoTract Key News
    7.19 Urotech
        7.19.1 Urotech Corporate Summary
        7.19.2 Urotech Business Overview
        7.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.19.4 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.19.5 Urotech Key News
    7.20 Baxter International
        7.20.1 Baxter International Corporate Summary
        7.20.2 Baxter International Business Overview
        7.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
        7.20.4 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
        7.20.5 Baxter International Key News
8 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, Analysis
    8.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, 2016-2027
    8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity of Key Manufacturers in Global Market
    8.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Benign Prostatic Hyperplasia (BPH) Treatment Devices Supply Chain Analysis
    10.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Value Chain
    10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Upstream Market
    10.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com